Drug intelligence / Profile preview

inactivated anti-SARS-CoV-2 immune plasma

Development stage: Unknown
Lead developer: Jinyintan Hospital
Modality: Recombinant Proteins and Enzymes
Administration: Intravenous

Overview

Inactivated anti-SARS-CoV-2 immune plasma is a therapeutic preparation of convalescent plasma derived from donors who have recovered from COVID-19. This plasma contains high titers of neutralizing antibodies specifically targeting the SARS-CoV-2 virus. The 'inactivated' designation refers to the pathogen reduction process (such as methylene blue and light treatment) applied to the plasma to eliminate potential residual viruses or other pathogens, ensuring recipient safety. Developed and studied by institutions like Wuhan Jinyintan Hospital, it is intended to provide passive immunity to patients with severe COVID-19 pneumonia by neutralizing viral particles and modulating the immune response.

Other names: anti-SARS-CoV-2 virus inactivated plasmaanti-SARS-CoV2 virus inactivated plasmaanti-SARS-CoV 2 virus inactivated plasmainactivated convalescent plasmaanti-SARS-CoV-2 immune plasmaanti-SARS-CoV2 immune plasmaanti-SARS-CoV 2 immune plasma

Targets

SARS-CoV-2 spike

Beyond the preview

Go deeper on inactivated anti-SARS-CoV-2 immune plasma.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on inactivated anti-SARS-CoV-2 immune plasma.

Explore the full profile